Filed: 5/3/2024ACC: 0000950123-24-003797
📋 What this filing means
VERSANT VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $103.14M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$103.14M
Total AUM (reported)
16.50M
Total Shares
Allocation by class
COMMON STOCK$103.14M100.0%
Portfolio Concentration
Top 3$77.85M75.5%
4–10$25.29M24.5%
Top 3 weight
75.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 16.50M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
16.50M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other7
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings7
Rows:
CRISPR Therapeutics AG
OTRShares498.56K
TypeSH
Market value$33.98M
32.95%
Sole
0.00
Shared
498.56K
None
0.00
Skye Bioscience, Inc.
OTRShares2.01M
TypeSH
Market value$31.40M
30.45%
Sole
0.00
Shared
2.01M
None
0.00
Repare Therapeutics, Inc.
OTRShares2.65M
TypeSH
Market value$12.47M
12.09%
Sole
0.00
Shared
2.65M
None
0.00
Gritstone Oncology, Inc.
OTRShares3.56M
TypeSH
Market value$9.15M
8.87%
Sole
0.00
Shared
3.56M
None
0.00
Adverum Biotechnologies, Inc.
OTRShares506.82K
TypeSH
Market value$7.17M
6.95%
Sole
0.00
Shared
506.82K
None
0.00
Passage Bio, Inc.
OTRShares4.96M
TypeSH
Market value$6.70M
6.49%
Sole
0.00
Shared
4.96M
None
0.00
Aligos Therapeutics, Inc.
OTRShares2.32M
TypeSH
Market value$2.27M
2.20%
Sole
0.00
Shared
2.32M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CRISPR Therapeutics AGOTR | Common Stock | 498.56K | SH | $33.98M 32.95% | 0.00 | 498.56K | 0.00 |
Skye Bioscience, Inc.OTR | Common Stock | 2.01M | SH | $31.40M 30.45% | 0.00 | 2.01M | 0.00 |
Repare Therapeutics, Inc.OTR | Common Stock | 2.65M | SH | $12.47M 12.09% | 0.00 | 2.65M | 0.00 |
Gritstone Oncology, Inc.OTR | Common Stock | 3.56M | SH | $9.15M 8.87% | 0.00 | 3.56M | 0.00 |
Adverum Biotechnologies, Inc.OTR | Common Stock | 506.82K | SH | $7.17M 6.95% | 0.00 | 506.82K | 0.00 |
Passage Bio, Inc.OTR | Common Stock | 4.96M | SH | $6.70M 6.49% | 0.00 | 4.96M | 0.00 |
Aligos Therapeutics, Inc.OTR | Common Stock | 2.32M | SH | $2.27M 2.20% | 0.00 | 2.32M | 0.00 |